Clinical Trials Sponsored by Janssen-Cilag Farmaceutica Ltda

Total 147 results

Janssen-Cilag Farmaceutica Ltda.

Completed

A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal (PsiProsper)

Schizophrenia

Portugal
Janssen-Cilag Farmaceutica Ltda.

Approved for marketing

Early Access Program (EAP) for Ibrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

B-cell Chronic Lymphocytic Leukemia

Brazil
Janssen-Cilag Farmaceutica Ltda.

Completed

An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol

Contraception

Brazil, Mexico
Janssen-Cilag Farmaceutica Ltda.

Completed

An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.

Binge Eating
Janssen-Cilag Farmaceutica Ltda.

Completed

A Study to Evaluate Virologic Response in Participants Newly Diagnosed With HIV-1

HIV

Portugal
Janssen-Cilag Farmaceutica Ltda.

Completed

The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life

Dementia
Janssen-Cilag Farmaceutica Ltda.

Completed

Study to Evaluate the Efficacy and Quality of Life of Long-Acting Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Brazil
Janssen-Cilag Farmaceutica Ltda.

Completed

A Study of Pharmacodynamic and Genetic Parameters of Abira-DES Study Participants (NCT02217566) - Participants With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Following Unresponsive Treatment With Diethylstilbestrol (EXPLORE)

Metastatic Castration-resistant Prostate Cancer

Brazil
Janssen-Cilag Farmaceutica Ltda.

Completed

Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate

Schizophrenia

Colombia, Mexico, Brazil
Janssen-Cilag Farmaceutica Ltda.

Completed

A Study to Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With Risperidone

Schizophrenia

Brazil
Janssen-Cilag Farmaceutica Ltda.
Janssen Korea, Ltd., Korea

No longer available

An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndromes

Hong Kong, Brazil, Thailand
University Hospital, Clermont-Ferrand
Janssen-Cilag Farmaceutica Ltda.

Completed

Alzheimer and Sleep

Alzheimer's Disease

France
Janssen Cilag Pharmaceutica S.A.C.I., Greece

Completed

A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease

Alzheimer Disease
Janssen Cilag Pharmaceutica S.A.C.I., Greece

Completed

A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures

Epilepsy | Seizures
Janssen Cilag Pharmaceutica S.A.C.I., Greece

Completed

An Observational Study Evaluating the Safety of Topiramate for the Prevention of Migraine

Migraine Disorders
Janssen Cilag Pharmaceutica S.A.C.I., Greece

Completed

Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.

Bacterial Infections | Helicobacter Infections
Janssen Cilag Pharmaceutica S.A.C.I., Greece

Completed

A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux | Heartburn
Janssen Cilag Pharmaceutica S.A.C.I., Greece

Completed

An Observational Study of the Safety of Topiramate in Adults and Children With Epilepsy

Seizures, Epileptic
Centocor, Inc.
Janssen-Cilag Farmaceutica, S.R.L.

Completed

A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma

Melanoma

United States, United Kingdom, Germany
Janssen-Cilag Ltd.

Recruiting

A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease (FUZION CD)

Fistulizing Crohns Disease | Perianal Crohns Disease

Netherlands, United States, Belgium, Korea, Republic of, Taiwan, Israel, Japan, Canada, Hungary, Germany, Greece, United Kingdom, Australia, Spain, Saudi Arabia, Poland, Turkey, Portugal, Czechia, Italy, Jordan, France
Janssen-Cilag Ltd.

Not yet recruiting

A Study of Participants With Moderate or Severe Major Depressive Disorder (MDD) Requiring Urgent Symptom Control in a Psychiatric Emergency (POWER)

Depressive Disorder, Major

United Kingdom
Janssen-Cilag Ltd.

Active, not recruiting

A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment (ESCAPE-LTE)

Depressive Disorder, Major

Taiwan, Turkey, Malaysia, Germany, Czechia, Korea, Republic of, Poland, Hungary, Argentina, Belgium, Bulgaria, Finland, Greece, South Africa
Janssen-Cilag Ltd.

Completed

A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease (POWER)

Crohn Disease

United States, Korea, Republic of, Netherlands, France, Austria, Italy, United Kingdom, Germany, Russian Federation, Spain, Czechia, Sweden
Janssen-Cilag Ltd.

Completed

Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab (STARDUST)

Crohn Disease

Belgium, Netherlands, United Kingdom, France, Czechia, Italy, Germany, Denmark, Spain, Portugal, Slovakia, Sweden
Janssen-Cilag Ltd.

Completed

A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice (FIRE)

Lymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-Cell

France
Janssen-Cilag Ltd.

Completed

A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation

Schizophrenia

France, Germany, Spain, Israel, Malaysia, Turkey, Taiwan, Greece, Korea, Republic of, Russian Federation, Netherlands, United Kingdom, Croatia, Denmark, Saudi Arabia
Janssen-Cilag Ltd.

Completed

Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia

Schizophrenia

France
Janssen-Cilag Ltd.

Completed

An Observational/Non-interventional, Study of NS3/4a Protease and NS5A Protein of Hepatitis C Virus in Brazilian Participants With Chronic HCV Infection (MAPPING)

Hepatitis C Virus

Brazil
Janssen-Cilag Ltd.

Completed

Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America (HOLA)

Lymphoma | Leukemia | Multiple Myeloma | Non-Hodgkin | Lymphoid

Argentina, Colombia, Mexico, Panama, Brazil, Chile, Guatemala
Janssen-Cilag Ltd.

Completed

A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled Children

Child Behavior Disorders | Learning Disorders
Janssen-Cilag Ltd.

Completed

A Registry Study of Participants With Multiple Myeloma in Latin America (MYLACRE)

Multiple Myeloma

Brazil, Argentina, Mexico, Colombia, Panama
Janssen-Cilag Ltd.

Completed

Treatment-Resistant Depression Cohort in Europe

Depressive Disorder, Treatment-Resistant

Portugal, Germany, Italy, Belgium, Spain, United Kingdom, Netherlands
Janssen-Cilag Ltd.

Completed

A Study to Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With Antipsychotics (REALAI)

Schizophrenia

Mexico, Brazil
Janssen-Cilag Ltd.

Completed

Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia

Schizophrenia

Brazil
Janssen-Cilag Ltd.

Recruiting

A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials (REALiTEC)

Relapsed/Refractory Multiple Myeloma (RRMM)

Spain, France
Janssen-Cilag Ltd.

Recruiting

A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide (ArtemisPRO)

Metastatic Hormone-sensitive Prostate Cancer

France, Germany, Spain, Greece, Austria, United Kingdom
Janssen-Cilag Ltd.

Terminated

Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque Psoriasis (G-CARE)

Psoriasis

Italy, Germany, Greece
Janssen-Cilag Ltd.

Terminated

A Study to Evaluate the Impact of Care4Today® IBD, a Smart System to Facilitate the Management of Crohn's Disease by Patients and Health Care Providers

Crohn Disease

United Kingdom
Janssen-Cilag Ltd.

Completed

Prospective Observational Study on Ustekinumab (Stelara) Assessing Efficacy and Healthcare Resource Utilization in Crohn's Disease (PROSE)

Crohn Disease

Sweden
Janssen-Cilag Ltd.

Completed

A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis (G-PLUS)

Psoriasis

Germany, France, Italy, Spain, United Kingdom
Janssen-Cilag Ltd.

Completed

Study to Describe the Actual Situation of Hepatitis C Treatment in Brazil (PICTURE)

Hepatitis C Virus

Brazil
Janssen-Cilag Ltd.

Completed

Early Access to Low-dose Ritonavir (TMC114/r) and Other Antiretrovirals (ARVs) for Treatment-naive or Early Treatment Experienced in HIV-1 Patients

HIV-1

Taiwan
Janssen-Cilag Ltd.

Completed

Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population

Helminthiasis | Amoebiasis

Mexico
Janssen-Cilag Ltd.

Completed

An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain

Cancer, Pain
Janssen-Cilag Ltd.

Completed

An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder
Janssen-Cilag Ltd.

Terminated

An Efficacy and Safety Study to Compare Fentanyl Ionsys and Routine Care With Intravenous (IV) Morphine Patient-controlled Analgesia (PCA) in Participants Who Have Undergone Elective Major Abdominal or Orthopedic Surgery

Pain, Postoperative

United Kingdom
Janssen-Cilag Ltd.

Completed

A Study of Prophylaxis for Migraine Patients With Topiramate in India (PROMPT-IN)

Migraine
Janssen-Cilag Ltd.,Thailand

Completed

National Cancer Institute Thai Cancer Anemia Survey

Cancer | Anemia

Thailand
Janssen-Cilag Ltd.,Thailand

Completed

A Study of Safety and Effectiveness of Ultracet in Patients With Chronic Cancer Pain

Cancer

Thailand
Janssen-Cilag Pty Ltd

Completed

A Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant Recipients on Tacrolimus (PRIDE)

Renal Transplantion | Kidney Transplantion

Australia

3

Subscribe